IR@PKUHSC  > 北京大学第一临床医学院  > 神经内科
学科主题临床医学
Current management of intracerebral haemorrhage in China: a national, multi-centre, hospital register study
Wei, Jade W.1,2; Huang, Yining3; Wang, Ji-Guang4; Liu, Ming5; Wong, Lawrence K. S.6; Huang, Qifang4; Wu, Li′ e(7); Heeley, Emma L.1,2; Arima, Hisatomi1,2; Anderson, Craig S.4; ChinaQUEST Investigators
刊名BMC NEUROLOGY
2011-01-30
DOI10.1186/1471-2377-11-16
11
收录类别SCI
文章类型Article
WOS标题词Science & Technology
类目[WOS]Clinical Neurology
研究领域[WOS]Neurosciences & Neurology
关键词[WOS]CEREBRAL INFARCTION ; ACUTE STROKE ; HEALTH ; SUBTYPES ; CLASSIFICATION ; GUIDELINES ; TRIAL
英文摘要

Background: We aimed to examine current practice of the management and secondary prevention of intracerebral haemorrhage (ICH) in China where the disease is more common than in Western populations.

Methods: Data on baseline characteristics, management in-hospital and post-stroke, and outcome of ICH patients are from the ChinaQUEST (QUality Evaluation of Stroke Care and Treatment) study, a multi-centre, prospective, 62 hospital registry in China during 2006-07.

Results: Nearly all ICH patients (n = 1572) received an intravenous haemodiluting agent such as mannitol (96%) or a neuroprotectant (72%), and there was high use of intravenous traditional Chinese medicine (TCM) (42%). Neurosurgery was undertaken in 137 (9%) patients; being overweight, having a low Glasgow Coma Scale (GCS) score on admission, and Total Anterior Circulation Syndrome (TACS) clinical pattern on admission, were the only baseline factors associated with this intervention in multivariate analyses. Neurosurgery was associated with nearly three times higher risk of death/disability at 3 months post-stroke (odd ratio [OR] 2.60, p < 0.001). Continuation of antihypertensives in-hospital and at 3 and 12 months post-stroke was reported in 732/935 (78%), 775/935 (83%), and 752/935 (80%) living patients with hypertension, respectively.

Conclusions: The management of ICH in China is characterised by high rates of use of intravenous haemodiluting agents, neuroprotectants, and TCM, and of antihypertensives for secondary prevention. The controversial efficacy of these therapies, coupled with the current lack of treatments of proven benefit, is a call for action for more outcomes based research in ICH.

语种英语
WOS记录号WOS:000287505600001
资助机构Macquarie Bank Foundation ; George Foundation ; AstraZeneca Pharmaceutical China ; George Institute for Global Health ; Australian Postgraduate Award
引用统计
被引频次:11[WOS]   [WOS记录]     [WOS相关记录]
文献类型期刊论文
条目标识符http://ir.bjmu.edu.cn/handle/400002259/61040
专题北京大学第一临床医学院_神经内科
作者单位1.Univ Sydney, Sydney, NSW 2006, Australia
2.Affiliated Hosp 1, Baotou Med Coll, Baotou, Peoples R China
3.Royal Prince Alfred Hosp, George Inst Global Hlth, Sydney, NSW, Australia
4.Peking Univ, Dept Neurol, Hosp 1, Beijing 100871, Peoples R China
5.Shanghai Jiao Tong Univ, Ctr Epidemiol Studies & Clin Trials, Ruijin Hosp, Sch Med, Shanghai 200030, Peoples R China
6.Sichuan Univ, Dept Neurol, W China Hosp, Chengdu 610064, Peoples R China
7.Chinese Univ Hong Kong, Prince Wales Hosp, Hong Kong, Hong Kong, Peoples R China
推荐引用方式
GB/T 7714
Wei, Jade W.,Huang, Yining,Wang, Ji-Guang,et al. Current management of intracerebral haemorrhage in China: a national, multi-centre, hospital register study[J]. BMC NEUROLOGY,2011,11.
APA Wei, Jade W..,Huang, Yining.,Wang, Ji-Guang.,Liu, Ming.,Wong, Lawrence K. S..,...&ChinaQUEST Investigators.(2011).Current management of intracerebral haemorrhage in China: a national, multi-centre, hospital register study.BMC NEUROLOGY,11.
MLA Wei, Jade W.,et al."Current management of intracerebral haemorrhage in China: a national, multi-centre, hospital register study".BMC NEUROLOGY 11(2011).
条目包含的文件
条目无相关文件。
个性服务
推荐该条目
保存到收藏夹
查看访问统计
导出为Endnote文件
谷歌学术
谷歌学术中相似的文章
[Wei, Jade W.]的文章
[Huang, Yining]的文章
[Wang, Ji-Guang]的文章
百度学术
百度学术中相似的文章
[Wei, Jade W.]的文章
[Huang, Yining]的文章
[Wang, Ji-Guang]的文章
必应学术
必应学术中相似的文章
[Wei, Jade W.]的文章
[Huang, Yining]的文章
[Wang, Ji-Guang]的文章
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。